Abstract
Introduction
Calcineurin inhibitors (CNIs) such as cyclosporine A (CSA) and tacrolimus (Tac) are essential immunosuppressive agents administered after organ transplantation. Severe CNIassociated neurotoxic adverse events are considered to be rare, but can sometimes result in fatal complications (1, 2) . (4) (5) (6) (7) (8) (4, (7) (8) (9) (10) . The clinical management of RPLS has therefore been focused on discontinuation of CNIs or on dose reduction strategies (3, 7, 10 
Neurotoxicity of CNIs has been reported in liver and kidney transplant recipients, especially those who have further complications of co-existing hypertension, renal insufficiency, or insufficient recovery of hepatic function after liver transplant (3, 4). One side effect of CNI treatment can be the occurrence of reversible posterior leukoencephalopathy syndrome (RPLS), which is now being increasingly reported due to widespread use of magnetic resonance imaging (MRI)
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treatment from CSA to Tac, rather than discontinuation or dose reduction of CSA. (3, 7, 10 (Fig. 3) . She was discharged without a neurological deficit. No rejection
Case Report
Emergent brain magnetic resonance imaging (MRI) revealed high signal intensities in the bilateral basal ganglia and occipital lobes by the fluid-attenuated inversion recovery (FLAIR) images (Fig. 2). The patient was suspected of having developed RPLS as a consequence of CSA administration. According to previous reports, discontinuation or marked reduction of CNIs is essential for the treatment of transplant recipients with RPLS
F i g u r e 4 . Cl i n i c a l c h a r t o f t h e p o s t t r a n s p l a n t c o u r s e wi t h i mmu n o s u p p r e s s i v e r e g i me n . episodes or neurological aftereffects have been detected through her clinical course.
The clinical course of the present case is shown in Fig. 4 .
Discussion
We have reported the successful treatment of a heart transplant recipient with RPLS by switching her immunosuppressive treatment from a CSA-based to a Tac-based regimen. To the best of our knowledge, this is the first case report to describe the successful treatment of RPLS by substitution of CNIs, from CSA to Tac. (4) (5) (6) (7) (8) 10 (14) .
An image feature of RPLS is reversible posterior predominant white and gray matter lesions on brain MRI (4-8). FLAIR images of MRI in particular can detect a subtle subcortical lesion and a cortical lesion in RPLS and are valuable for diagnosis of this disease. RPLS after organ transplantation is now being increasingly reported due to the widespread use of MRI
According to previous reports, discontinuation or marked reduction of CNIs was essential for the treatment of transplant recipients with RPLS (3, 7, 10 
